HATCH Company Microdermics Closes $1 Million Funding Round
HATCH startup company Microdermics has developed the only commercially scalable, low-cost, customizable, metal, hollow, microneedle platform, to provide efficient delivery of vaccines and biologics — addressing the reliance worldwide on the 160-year-old, generic hypodermic needle. The novel drug delivery system is customizable, less painful, and addresses widespread “needle phobia”. Read the full story here.
ICICS/ECE/IEEE Workshop on Future Communications and Multimedia Systems
This May 12, 2017 workshop, co-hosted by ICICS, the Department of Electrical and Computer Engineering, and the IEEE, will feature five industry speakers presenting their views on Connectivity for the Internet of Things (IoT) as well as a poster session during which UBC students and faculty present their ongoing research. Don’t miss […]